Klinische und diagnostische Befunde bei Exposition gegenüber Nanopartikeln und neuen Materialien

Mittmann-Frank, Michaela; Berger, Hendrik; Pföhler, Claudia; Bücker, Arno; Wilkens, Heinrike; Arzt, Eduard; Schmitt, Karl-Peter; Wennemuth, Gunther; Hannig, Matthias; Buchter, Axel

doi:10.1007/bf03344310

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2010

2019

Publication Types

Select...

Article3

Other2

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 6 publications

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Zirkoniumdioxid (alveolengängige Fraktion) [MAK value documentation in German language, 2019]

Hartwig

2019

The MAK‐Collection for Occupational Health and Safety

View full text Add to dashboard Cite

The German Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area has re‐evaluated zirconium dioxide [ 1314‐23‐4 ]. Zirconium dioxide is a biopersistent granular dust. Therefore, the respirable fraction of zirconium dioxide dust is classified in Carcinogen Category 4 and a maximum concentration at the workplace (MAK value) of 0.3 mg/m 3 × material density is established for the respirable fraction in analogy to the other biopersistent granular dusts. Additionally, this fraction is classified in Peak Limitation Category II with an excursion factor of 8. As zirconium dioxide is not systemically distributed and accumulates only locally in the lungs, no developmental toxicity is expected to occur at the MAK value of 0.3 mg/m 3 × material density (respirable fraction). Accordingly, zirconium dioxide is classified in Pregnancy Risk Group C. Zirconium dioxide is not a sensitizer and is not taken up via the skin in toxicologically relevant amounts.

show abstract